BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 3764938)

  • 1. Inhibition of the acute toxicity of methyl chloride in male B6C3F1 mice by glutathione depletion.
    Chellman GJ; White RD; Norton RM; Bus JS
    Toxicol Appl Pharmacol; 1986 Oct; 86(1):93-104. PubMed ID: 3764938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible role of glutathione in chromium(VI) metabolism and toxicity in rats.
    Standeven AM; Wetterhahn KE
    Pharmacol Toxicol; 1991 Jun; 68(6):469-76. PubMed ID: 1891442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of glutathione depletion by buthionine sulphoximine on 1-cyano-3,4-epithiobutane toxicity.
    VanSteenhouse JL; Fettman MJ; Gould DH
    Food Chem Toxicol; 1991 Mar; 29(3):153-7. PubMed ID: 2032656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutathione depletion by methyl chloride and association with lipid peroxidation in mice and rats.
    Kornbrust DJ; Bus JS
    Toxicol Appl Pharmacol; 1984 Mar; 72(3):388-99. PubMed ID: 6710490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel model of continuous depletion of glutathione in mice treated with L-buthionine (S,R)-sulfoximine.
    Watanabe T; Sagisaka H; Arakawa S; Shibaya Y; Watanabe M; Igarashi I; Tanaka K; Totsuka S; Takasaki W; Manabe S
    J Toxicol Sci; 2003 Dec; 28(5):455-69. PubMed ID: 14746349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promotion of trans-platinum in vivo effects on renal heme and hemoprotein metabolism by D,L-buthionine-S,R-sulfoximine. Possible role of glutathione.
    Mayer RD; Maines MD
    Biochem Pharmacol; 1990 May; 39(10):1565-71. PubMed ID: 2337413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective modulation of glutathione in mouse brain regions and its effect on acrylamide-induced neurotoxicity.
    Shivakumar BR; Ravindranath V
    Biochem Pharmacol; 1992 Jan; 43(2):263-9. PubMed ID: 1739414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of depletion of nonprotein sulfhydryls by diethyl maleate plus buthionine sulfoximine on renal uptake of mercury in the rat.
    Baggett JM; Berndt WO
    Toxicol Appl Pharmacol; 1986 May; 83(3):556-62. PubMed ID: 3705075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of glutathione levels on aflatoxin B1-DNA binding in livers and kidneys of male rats and hamsters pretreated with buthionine sulfoximine and dimethylmaleate.
    Gopalan-Kriczky P; Hiruma S; Lotlikar PD
    Cancer Lett; 1994 Jan; 76(1):25-30. PubMed ID: 8124663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p-Dichlorobenzene-induced hepatotoxicity in mice depleted of glutathione by treatment with buthionine sulfoximine.
    Mizutani T; Nakahori Y; Yamamoto K
    Toxicology; 1994; 94(1-3):57-67. PubMed ID: 7801330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the long-term depletion of reduced glutathione in mice administered L-buthionine-S,R-sulfoximine.
    Sun JD; Ragsdale SS; Benson JM; Henderson RF
    Fundam Appl Toxicol; 1985 Oct; 5(5):913-9. PubMed ID: 2866140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Styrene-induced hepatotoxicity in mice depleted of glutathione.
    Mizutani T; Irie Y; Nakanishi K
    Res Commun Mol Pathol Pharmacol; 1994 Dec; 86(3):361-74. PubMed ID: 7712112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxic effects of acute glutathione depletion by buthionine sulfoximine and dimethylfumarate on murine mammary carcinoma cells.
    Dethlefsen LA; Lehman CM; Biaglow JE; Peck VM
    Radiat Res; 1988 May; 114(2):215-24. PubMed ID: 3375425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of modulation of hepatic glutathione on biotransformation and covalent binding of aflatoxin B1 to DNA in the mouse.
    Monroe DH; Eaton DL
    Toxicol Appl Pharmacol; 1988 Jun; 94(1):118-27. PubMed ID: 3131927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue-specific changes in glutathione and cysteine after buthionine sulfoximine treatment of rats and the potential for artifacts in thiol levels resulting from tissue preparation.
    Standeven AM; Wetterhahn KE
    Toxicol Appl Pharmacol; 1991 Feb; 107(2):269-84. PubMed ID: 1994510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of buthionine sulfoximine on the development of ozone-induced pulmonary fibrosis.
    Sun JD; Pickrell JA; Harkema JR; McLaughlin SI; Hahn FF; Henderson RF
    Exp Mol Pathol; 1988 Oct; 49(2):254-66. PubMed ID: 2901982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemosensitization of L-phenylalanine mustard by the thiol-modulating agent buthionine sulfoximine.
    Kramer RA; Greene K; Ahmad S; Vistica DT
    Cancer Res; 1987 Mar; 47(6):1593-7. PubMed ID: 3815359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organ-selective switching of 3-methylindole toxicity by glutathione depletion.
    Yost GS; Kuntz DJ; McGill LD
    Toxicol Appl Pharmacol; 1990 Mar; 103(1):40-51. PubMed ID: 2315931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of modulators of glutathione synthesis on the hepatotoxicity of 2-methylfuran.
    Ravindranath V; Boyd MR
    Biochem Pharmacol; 1991 May; 41(9):1311-8. PubMed ID: 2018563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatotoxicity of eugenol in mice depleted of glutathione by treatment with DL-buthionine sulfoximine.
    Mizutani T; Satoh K; Nomura H; Nakanishi K
    Res Commun Chem Pathol Pharmacol; 1991 Feb; 71(2):219-30. PubMed ID: 2047567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.